Ulotaront Phase III Schizophrenia Setback For Sumitomo, Otsuka Alliance

'High Placebo Response'

 
• By Ian Haydock
  
Ulotaron's Phase III DIAMOND 1 and 2 studies missed the primary endpoints
ulotaront misses target in two Phase III trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip